Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB1900542	盐酸安非他酮缓释片（I）	bupropion hydrochloride	Tablet, extended release	Chemical Drugs(5.1)	Supplementary Application	2019-05-20	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2020-03-06	view
JYHB1900543	盐酸安非他酮缓释片（I）	bupropion hydrochloride	Tablet, extended release	Chemical Drugs(5.1)	Supplementary Application	2019-05-20	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2020-03-06	view
CYHS1800392	盐酸安非他酮缓释片（I）	bupropion hydrochloride	Tablet, extended release	Chemical Drugs(3)	Generic Drug	2018-11-02	石药集团欧意药业有限公司	CSPC OUYI Pharmaceutical Co Ltd	In Review	2018-11-01	view
CYHS1800393	盐酸安非他酮缓释片（I）	bupropion hydrochloride	Tablet, extended release	Chemical Drugs(3)	Generic Drug	2018-11-02	石药集团欧意药业有限公司	CSPC OUYI Pharmaceutical Co Ltd	In Review	2018-11-01	view
JXHS1800021	盐酸安非他酮缓释片（I）	bupropion hydrochloride	Tablet, extended release	Chemical Drugs(5.1)	Import Drug Application	2018-05-09	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2020-03-06	view
JXHS1800022	盐酸安非他酮缓释片（I）	bupropion hydrochloride	Tablet, extended release	Chemical Drugs(5.1)	Import Drug Application	2018-05-09	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2020-03-06	view